We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

106 hedge funds and large institutions have $700M invested in Assembly Biosciences in 2020 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 49 increasing their positions, 23 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 23

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

56% more capital invested

Capital invested by funds: $449M → $700M (+$251M)

8% more funds holding

Funds holding: 98 → 106 (+8)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.09% less ownership

Funds ownership: 7.73% → 7.64% (-0.09%)

Holders
106
Holders Change
+8
Holders Change %
+8.16%
% of All Funds
2.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
49
Reduced
23
Closed
8
Calls
$542K
Puts
–
Net Calls
+$542K
Net Calls Change
+$1.31M

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$10.9M
2
State Street
State Street
Massachusetts
+$9.29M
3
BCPEMI
Bain Capital Public Equity Management II
Massachusetts
+$6.86M
4
BlackRock
BlackRock
New York
+$4.8M
5
MWNA
Marshall Wace North America
New York
+$3.06M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$32.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.98M
3
Morgan Stanley
Morgan Stanley
New York
-$2.82M
4
AC
Armistice Capital
New York
-$2.49M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$4.92M +$537K +2,301 +15%
IC
27
Ikarian Capital
Texas
$3.67M – – –
Barclays
28
Barclays
United Kingdom
$3.67M +$8.87K +38 +0.3%
JP Morgan Chase
29
JP Morgan Chase
New York
$3.63M -$1.49M -6,382 -33%
PIM
30
Platinum Investment Management
Australia
$3.61M – – –
AI
31
Atom Investors
Texas
$3.38M +$193K +828 +7%
B
32
Bailard
California
$3.29M -$1.43M -6,125 -34%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$3.28M +$219K +938 +9%
Prudential Financial
34
Prudential Financial
New Jersey
$3.08M +$17.7K +76 +0.7%
BFM
35
Boothbay Fund Management
New York
$2.5M +$19.4K +83 +0.9%
Goldman Sachs
36
Goldman Sachs
New York
$2.09M -$756K -3,239 -30%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$1.99M +$278K +1,192 +20%
Two Sigma Investments
38
Two Sigma Investments
New York
$1.8M +$463K +1,986 +45%
Wells Fargo
39
Wells Fargo
California
$1.61M +$583K +2,499 +77%
Swiss National Bank
40
Swiss National Bank
Switzerland
$1.59M +$266K +1,141 +25%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$1.58M +$388K +1,663 +42%
Renaissance Technologies
42
Renaissance Technologies
New York
$1.58M +$307K +1,317 +30%
CS
43
Credit Suisse
Switzerland
$1.4M +$635K +2,721 +120%
PAM
44
Panagora Asset Management
Massachusetts
$1.35M +$1.13M +4,842 New
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$1.15M +$97.3K +417 +11%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$1.08M +$60K +257 +7%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$1.07M +$35K +150 +4%
AA
48
ALPS Advisors
Colorado
$1.04M -$229K -980 -21%
Man Group
49
Man Group
United Kingdom
$954K -$36.9K -158 -4%
DCM
50
DAFNA Capital Management
California
$830K – – –
1
2
3 4 5

ASMB Hedge Fund Activity: Q2 2020 in Review

106 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q2 2020, worth a combined $700M — up 56% from $449M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ASMB positions and 8 closed out — a net gain of 8 holders — while 49 added to existing stakes and 23 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $10.9M. The largest seller was Victory Capital Management, cutting an estimated $32.9M.

  • 106 institutional investors held Assembly Biosciences (ASMB) as of Q2 2020, up from 98 in Q1 2020.
  • Funds reported $700M of Assembly Biosciences stock for Q2 2020, up 56% quarter-over-quarter.
  • 16 funds opened new Assembly Biosciences positions in Q2 2020 and 8 closed out, a net change of +8 holders.
  • The largest Assembly Biosciences buyer in Q2 2020 was EcoR1 Capital, an estimated $10.9M added.
  • The largest Assembly Biosciences seller in Q2 2020 was Victory Capital Management, an estimated $32.9M sold.

Based on aggregated 13F filings for Q2 2020.